Diagonal Bio Balance Sheet Health
Financial Health criteria checks 5/6
Diagonal Bio has a total shareholder equity of SEK18.3M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK28.5M and SEK10.3M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 1.86m |
| Equity | SEK 18.26m |
| Total liabilities | SEK 10.26m |
| Total assets | SEK 28.52m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DIABIO's short term assets (SEK4.2M) do not cover its short term liabilities (SEK10.3M).
Long Term Liabilities: DIABIO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: DIABIO is debt free.
Reducing Debt: DIABIO has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable DIABIO has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: DIABIO is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 16.2% per year.